A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

BACKGROUND: Olanzapine rapid-acting intramuscular (IM) injection is an atypical antipsychotic drug already used overseas and recently approved in Japan. The objective of this study was to confirm the efficacy of rapid-acting IM olanzapine 10 mg was greater than IM placebo in patients with exacerbati...

Descripción completa

Detalles Bibliográficos
Autores principales: Katagiri, Hideaki, Fujikoshi, Shinji, Suzuki, Takuya, Fujita, Kiyoshi, Sugiyama, Naoya, Takahashi, Michihiro, Gomez, Juan-Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556331/
https://www.ncbi.nlm.nih.gov/pubmed/23311957
http://dx.doi.org/10.1186/1471-244X-13-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556331/
https://www.ncbi.nlm.nih.gov/pubmed/23311957
http://dx.doi.org/10.1186/1471-244X-13-20

Ejemplares similares